Please login to the form below

Not currently logged in
Email:
Password:

Baraclude interim data issued by BMS

Bristol-Myers Squibb (BMS) has announced positive 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis

Bristol-Myers Squibb (BMS) has announced 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis, in which Baraclude demonstrated greater viral suppression compared to adefovir.

"This study represents an important first step in addressing an unmet medical need, as this is one of the first comparative studies to evaluate the safety and efficacy of antiviral therapy in this difficult-to-treat patient population," said Professor Hugo Cheinquer, ETV-048 study investigator and associate professor of gastroenterology and hepatology, Universidade Federal Do Rio Grande Do Sul, Brazil. "Chronic hepatitis B is a lifelong disease and these data suggest that treatment with Baraclude may offer chronic hepatitis B patients with decompensated cirrhosis a treatment option."

Decompensated cirrhosis is characterised by severe scarring of the liver caused by chronic liver inflammation, including inflammation associated with chronic hepatitis B infection. It is estimated that 15 to 25 per cent of chronic hepatitis B patients die from complications of liver disease. Currently, the median survival rate in decompensated patients is two to three years, with only 28 per cent of patients surviving for more than five years. The treatment of chronic hepatitis B patients with decompensated cirrhosis remains an area of unmet medical need, and these patients often require liver transplant.

2nd November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics